List of Glenmark Pharmaceuticals patents

Patents where

Current Assignee

Name

Glenmark Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9078923 Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine	Patent 9078923 was granted and assigned to Glenmark Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9078923	July 14, 2015
‌ US Patent 7414143 Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman	Patent 7414143 was granted and assigned to Glenmark Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7414143	August 19, 2008
‌ US Patent 9518048 Process for the preparation of teneligliptin	Patent 9518048 was granted and assigned to Glenmark Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9518048	December 13, 2016
‌ US Patent 7230002 Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof	Patent 7230002 was granted and assigned to Glenmark Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7230002	June 12, 2007
‌ US Patent 7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them	Patent 7238725 was granted and assigned to Glenmark Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7238725	July 3, 2007
‌ US Patent 9670160 Process for the preparation of tofacitinib and intermediates thereof	Patent 9670160 was granted and assigned to Glenmark Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9670160	June 6, 2017
‌ US Patent 7291745 Process for the preparation of perindopril	Patent 7291745 was granted and assigned to Glenmark Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7291745	November 6, 2007
‌ US Patent 9567332 Process for the preparation and purification of apixaban	Patent 9567332 was granted and assigned to Glenmark Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	9567332	February 14, 2017
‌ US Patent 9499475 Process for the preparation of arformoterol or salt thereof	Patent 9499475 was granted and assigned to Glenmark Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9499475	November 22, 2016
‌ US Patent 9695159 Process for preparation of canagliflozin	Patent 9695159 was granted and assigned to Glenmark Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9695159	July 4, 2017
‌ US Patent 10106483 Process for preparation of azelaic acid	Patent 10106483 was granted and assigned to Glenmark Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	10106483	October 23, 2018
‌ US Patent 9227958 Amorphous and crystalline forms of aprepitant and processes for the preparation thereof	Patent 9227958 was granted and assigned to Glenmark Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	9227958	January 5, 2016
‌ US Patent D914095 Label	Patent D914095 was granted and assigned to Glenmark Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	D914095	March 23, 2021
‌ US Patent 10138190 Process for preparation of ospemifene	Patent 10138190 was granted and assigned to Glenmark Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	10138190	November 27, 2018
‌ US Patent 7649096 Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide	Patent 7649096 was granted and assigned to Glenmark Pharmaceuticals on January, 2010 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7649096	January 19, 2010
‌ US Patent 9593119 Process for the preparation of dipeptidylpeptidase inhibitors	Patent 9593119 was granted and assigned to Glenmark Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	9593119	March 14, 2017
‌ US Patent 9440927 Process for preparation of substituted 3'-hydroazino-diphenyl-3-carboxylic acid compounds	Patent 9440927 was granted and assigned to Glenmark Pharmaceuticals on September, 2016 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	9440927	September 13, 2016
‌ US Patent D804015 Inhaler	Patent D804015 was granted and assigned to Glenmark Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	D804015	November 28, 2017
‌ US Patent 9663505 Process for the preparation of rivaroxaban	Patent 9663505 was granted and assigned to Glenmark Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9663505	May 30, 2017
‌ US Patent 7312329 Process for the preparation of pyrimidine derivatives	Patent 7312329 was granted and assigned to Glenmark Pharmaceuticals on December, 2007 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	7312329	December 25, 2007
‌ US Patent D797920 Inhaler	Patent D797920 was granted and assigned to Glenmark Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	D797920	September 19, 2017
‌ US Patent 9776985 Process for preparation of alogliptin	Patent 9776985 was granted and assigned to Glenmark Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9776985	October 3, 2017
‌ US Patent 8673356 Stable fixed dose topical formulation	Patent 8673356 was granted and assigned to Glenmark Pharmaceuticals on March, 2014 by the United States Patent and Trademark Office.		Glenmark Pharmaceuticals	United States Patent and Trademark Office	8673356	March 18, 2014
‌ US Patent 9840456 Process for preparation of dimethyl fumarate	Patent 9840456 was granted and assigned to Glenmark Pharmaceuticals on December, 2017 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	9840456	December 12, 2017
‌ US Patent 10357622 Dry powder inhaler	Patent 10357622 was granted and assigned to Glenmark Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	Glenmark Pharmaceuticals	Glenmark Pharmaceuticals	United States Patent and Trademark Office	10357622	July 23, 2019

Results per page:

29 results

0 selected

29 results

0 selected